THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Recombinant Canine Interferon-gamma (rCaIFN-gamma) is a non-glycosylated polypeptide chain containing 143 amino acids. It is produced using Escherichia coli (E. coli) as the expression system . The mature form of canine IFN-gamma exists as a noncovalently linked homodimer of 20-25 kDa variably glycosylated subunits .
The biological activity of recombinant canine IFN-gamma is measured by its antiviral activity on A-72 canine fibroma cells infected with vesicular stomatitis virus (VSV). The effective dose (ED50) for this effect is typically in the range of 0.3-2.0 ng/mL . This cytokine is fully biologically active when compared to the standard, with a specific activity of greater than 5.0 x 10^5 IU/mg .
Recombinant canine IFN-gamma is used in various research and clinical applications, including:
The recombinant protein is typically lyophilized from a filtered solution and can be reconstituted in sterile phosphate-buffered saline (PBS) containing at least 0.1% human or bovine serum albumin. It is stable for 12 months when stored at -20 to -70°C as supplied. After reconstitution, it can be stored for 1 month at 2-8°C under sterile conditions and for 3 months at -20 to -70°C under sterile conditions .